Jeffrey Nau, Oyster Point Pharma CEO October 18, 2021 10:45 AM EDT PharmaFDA+ Oyster Point Pharma now has its first FDA-approved product — Tyrvaya. And the biotech has taken a unique route to get there by using an old drug with a storied past. The New Jersey biotech announced this morning that the FDA has...